[1] FELÍCIO J S,KOURY C C,CARVALHO C T,et al.Present insights on cardiomyopathy in diabetic patients[J].Curr Diabetes Rev,2016,12(4):384-395.
[2] 李洁,刘乃丰.糖尿病心肌病发病机制的研究进展[J].现代医学,2006,34(4):292-295.
[3] LIU Q,WANG S,CAI L.Diabetic cardiomyopathy and its mechanisms:Role of oxidative stress and damage[J].J Diabetes Investig,201,5(6):623-634.
[4] AFRIN M R,ARUMUGAM S,WAHED M I I,et al.Attenuation of endoplasmic reticulum stress-mediated liver damage by mulberry leaf diet in streptozotocin-induced diabetic rats[J].Am J Chin Med,2016,44(1):87-101.
[5] TIAN C,ALOMAR F,MOORE C J,et al.Reactive carbonyl species and their roles in sarcoplasmic reticulum Ca2+ cycling defect in the diabetic heart[J].Heart Fail Rev,2014,19(1):101-112.
[6] MAYA L,VILLARREAL F J.Diagnostic approaches for diabetic cardiomyopathy and myocardial fibrosis[J].J Mol Cell Cardiol,2010,48(3):524-529.
[7] GILCA G E,STEFANESCU G,BADULESCU O,et al.Diabetic cardiomyopathy:current approach and potential diagnostic and therapeutic targets[J].J Diabetes Res,2017,2017:1310256.
[8] TAKADAA,MIKI T,KUNO A,et al.Role of ER stress in ventricular contractile dysfunction in type 2 diabetes[J].Plos One,2012,7(6):e39893-e39893.
[9] ZHU G,LEE A S.Role of the unfolded protein response,GRP78 and GRP94 in organ homeostasis[J].J Cell Physiol,2015,230(7):1413-1420.
[10] LIU M,DUDLEY S C Jr.Role for the unfolded protein response in heart disease and cardiac arrhythmias[J].Int J Mol Sci,2015,17(1):pii:E52.
[11] LAKSHMANAN A P,HARIMA M,SUZUKI K,et al.The hyperglycemia stimulated myocardial endoplasmic reticulum (ER) stress contributes to diabetic cardiomyopathy in the transgenic non-obese type 2 diabetic rats:a differential role of unfolded protein response (UPR) signaling proteins[J].Int J Biochem Cell Biol,2013,45(2):438-447.
[12] FRATI G,SCHIRONE L,CHIMENTI I,et al.An overview of the inflammatory signalling mechanisms in the myocardium underlying the development of diabetic cardiomyopathy[J].Cardiovasc Res,2017,113(4):378-388.
[13] WU T,DONG Z,GENG J,et al.Valsartan protects against ER stress-induced myocardial apoptosis via CHOP/Puma signaling pathway in streptozotocin-induced diabetic rats[J].Eur J Pharm Sci,2011,42(5):496-502.
[14] SHAREEF M A,ANWER L A,POIZAT C.Cardiac SERCA2A/B:therapeutic targets for heart failure[J].Eur J Pharmacol,2014,724(1):1-8.
[15] WU P,ZHAI Y,LI D.The function and significance of SERA2a in congestive heart failure:an analysis of gene therapy trials[J].Histol Histopathol,2017,32(8):767-777.
[16] AKHTAR M S,PILLAI K K,HASSANM Q,et al.Levosimendan reduces myocardial damage and improves cardiodynamics in streptozotocin induced diabetic cardiomyopathy via SERCA2a/NCX1 pathway[J].Life Sciences,2016,153:55-65.
[17] RAJESH M,BÁTKAI S,KECHRID M,et al.Cannabinoid 1 receptor promotes cardiac dysfunction,oxidative stress,inflammation,and fibrosis in diabetic cardiomyopathy[J].Diabetes,2012,61(3):716-727. |